Jenkem Technology Co

Jenkem Technology Co Inventory

The Inventory of Jenkem Technology Co (688356.SS) as of Oct 28, 2026 is 77.61 M CNY. In the previous year, Inventory was 106.45 M CNY — a change of -27.09% (lower).

Inventory

77.61 MCNY

YoY

-27.09%

Last updated:

Inventory of Jenkem Technology Co is 2025 77.61 M CNY. Inventory of Jenkem Technology Co was 2024 106.45 M CNY. It decreases by -27.09% lower compared to the previous year.

The Jenkem Technology Co Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2018
12.19 M CNY
Jan 1, 2019
16.87 M CNY
Jan 1, 2020
23.44 M CNY
Jan 1, 2021
41.41 M CNY
Jan 1, 2022
65.53 M CNY
Jan 1, 2023
90.80 M CNY
Jan 1, 2024
106.45 M CNY
Jan 1, 2025
77.61 M CNY
The Jenkem Technology Co Inventory history
YEARInventoryYoY
77.61 MCNY-27.09%
106.45 MCNY+17.23%
90.80 MCNY+38.57%
65.53 MCNY+58.24%
41.41 MCNY+76.70%
23.44 MCNY+38.94%
16.87 MCNY+38.36%
12.19 MCNY+26.81%
9.61 MCNY+16.52%
8.25 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Jenkem Technology Co Stock analysis

What does Jenkem Technology Co do? Jenkem Technology Co., Ltd. generates revenue through the research, development, production, and sales of medical polyethylene glycol (PEG) and its active derivatives. The company's primary products are sold to pharmaceutical companies, research institutions, and medical device manufacturers that use these materials in drug development and production. Technical services such as patent and non-patent technology licensing, as well as R&D services, also contribute to the company's income. The firm's customer segments include entities involved in drug research, development, and production, as well as scientific research organizations. The company's business model focuses on providing specialized materials and technical support for the medical and pharmaceutical sectors. Medical polyethylene glycol and its active derivatives serve as critical components in various medical applications, driving demand from industry partners. By offering both physical products and intellectual property services, Jenkem Technology diversifies its revenue streams within the healthcare technology space. Jenkem Technology Co., Ltd. operates with a clear focus on the medical and pharmaceutical industries, targeting clients that require high-quality PEG-based materials for their research and manufacturing processes. The company's technical services, including licensing and R&D support, further strengthen its position as a supplier of essential materials and solutions in the healthcare sector. Jenkem Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jenkem Technology Co stock

Inventory of Jenkem Technology Co is 77.61 M CNY in 2025.

Inventory of Jenkem Technology Co changed from 106.45 M CNY to 77.61 M CNY, representing a -27.09% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Inventory Jenkem Technology Co since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Jenkem Technology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Jenkem Technology Co

All Key Metrics — Jenkem Technology Co